VEGFA and COVID-19: Accordingly, increased levels of proangiogenic factors such as vascular endothelial growth factor (VEGF), fibroblast growth factor-2, and hypoxia-inducible factor-1α (HIF-1α) have been detected in COVID-19 patients [34,114–116].